Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

We estimated the effectiveness of booster doses of monovalent mRNA COVID-19 vaccines against Omicron-associated severe outcomes among adults in Ontario, Canada. We used a test-negative design to estimate vaccine effectiveness (VE) against hospitalization or death among SARS-CoV-2-tested adults aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Grewal, Ramandip, Nguyen, Lena, Buchan, Sarah A., Wilson, Sarah E., Nasreen, Sharifa, Austin, Peter C., Brown, Kevin A., Fell, Deshayne B., Gubbay, Jonathan B., Schwartz, Kevin L., Tadrous, Mina, Wilson, Kumanan, Kwong, Jeffrey C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990563/
https://www.ncbi.nlm.nih.gov/pubmed/36882416
http://dx.doi.org/10.1038/s41467-023-36566-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990563/
https://www.ncbi.nlm.nih.gov/pubmed/36882416
http://dx.doi.org/10.1038/s41467-023-36566-1

Ejemplares similares